Paper36935431
Targeted molecular profiling of solid tumours-Indian tertiary cancer centre experience.
Gurav M and 7 others. J Cancer Res Clin Oncol, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Targeted molecular profiling of solid tumours-Indian tertiary cancer centre experience. Papers, record 36935431. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36935431
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins B-raf | Major topic |
| Lung Neoplasms | Major topic |
| Humans | |
| Proto-Oncogene Proteins p21(ras) | |
| Mutation | |
| ErbB Receptors | |
| Receptor Protein-Tyrosine Kinases | |
| High-Throughput Nucleotide Sequencing |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27678269 | Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL. | Virchows Arch | 2017 | https://conductscience.org/library/papers/27678269 | PubMed |
| 2 | 29250205 | Next generation sequencing: clinical applications in solid tumours. | Memo | 2017 | https://conductscience.org/library/papers/29250205 | PubMed |
| 3 | 31445211 | A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples. | J Mol Diagn | 2019 | https://conductscience.org/library/papers/31445211 | PubMed |
| 4 | 29786478 | Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke. | Int J Stroke | 2018 | https://conductscience.org/library/papers/29786478 | PubMed |
| 5 | 31251989 | Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis. | J Mol Diagn | 2019 | https://conductscience.org/library/papers/31251989 | PubMed |
| 6 | 26868357 | Precision oncology: origins, optimism, and potential. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/26868357 | PubMed |
| 7 | 30766968 | Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer. | JCO Precis Oncol | 2018 | https://conductscience.org/library/papers/30766968 | PubMed |
| 8 | 26680590 | Advances in clinical next-generation sequencing: target enrichment and sequencing technologies. | Expert Rev Mol Diagn | 2016 | https://conductscience.org/library/papers/26680590 | PubMed |
| 9 | 33127962 | Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis. | Sci Rep | 2020 | https://conductscience.org/library/papers/33127962 | PubMed |
| 10 | 26423591 | Overview of Target Enrichment Strategies. | Curr Protoc Mol Biol | 2015 | https://conductscience.org/library/papers/26423591 | PubMed |
| 11 | 35135162 | Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research Experience. | JCO Precis Oncol | 2018 | https://conductscience.org/library/papers/35135162 | PubMed |
| 12 | 32947236 | KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report. | Transl Oncol | 2020 | https://conductscience.org/library/papers/32947236 | PubMed |
| 13 | 30089598 | The prognostic value of TP53 and its correlation with EGFR mutation in advanced non-small cell lung cancer, an analysis based on cBioPortal data base. | Lung Cancer | 2018 | https://conductscience.org/library/papers/30089598 | PubMed |
| 14 | 21829508 | PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. | PLoS One | 2011 | https://conductscience.org/library/papers/21829508 | PubMed |
| 15 | 29625050 | Oncogenic Signaling Pathways in The Cancer Genome Atlas. | Cell | 2018 | https://conductscience.org/library/papers/29625050 | PubMed |
| 16 | 33009475 | Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. | Sci Rep | 2020 | https://conductscience.org/library/papers/33009475 | PubMed |
| 17 | 22797725 | Association analyses identify multiple new lung cancer susceptibility loci and their interactions with smoking in the Chinese population. | Nat Genet | 2012 | https://conductscience.org/library/papers/22797725 | PubMed |
| 18 | 26212640 | Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity. | Sci Rep | 2015 | https://conductscience.org/library/papers/26212640 | PubMed |
| 19 | 27242894 | TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients. | Front Genet | 2016 | https://conductscience.org/library/papers/27242894 | PubMed |
| 20 | 29954777 | Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29954777 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42010540 | Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42010540 | PubMed |
| 41108159 | Dual inhibition of BRAF for cancer treatment: advances and therapeutic potential. | Future Med Chem | 2025 | https://conductscience.org/library/papers/41108159 | PubMed |
| 38717047 | Microfluidics-based EGFR mutation detection and its implication in the resource-limited clinical setting. | Int J Exp Pathol | 2024 | https://conductscience.org/library/papers/38717047 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALK | 238 | PubTator's text mining | https://conductscience.org/library/genes/238 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| NRAS | 4893 | PubTator's text mining | https://conductscience.org/library/genes/4893 | NCBI Gene |
| PIK3CA | 5290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36935431
GET https://conductscience.org/api/papers/v1/36935431/references?page=2